Pictet Asset Management (Switzerland)’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $233K | Buy |
9,481
+849
| +10% | +$20.8K | ﹤0.01% | 1644 |
|
|
2023
Q1 | $201K | Hold |
8,632
| – | – | ﹤0.01% | 1730 |
|
|
2022
Q4 | $218K | Buy |
+8,632
| New | +$218K | ﹤0.01% | 1682 |
|
|
2022
Q3 | – | Sell |
-49,243
| Closed | -$1.25M | – | 1609 |
|
|
2022
Q2 | $1.25M | Buy |
49,243
+4,493
| +10% | +$114K | ﹤0.01% | 1006 |
|
|
2022
Q1 | $1.15M | Buy |
44,750
+11,466
| +34% | +$295K | ﹤0.01% | 1036 |
|
|
2021
Q4 | $1.39M | Buy |
+33,284
| New | +$1.39M | ﹤0.01% | 1032 |
|